Fenwick & West advised Calm on the deal while O’Melveny represented Ripple Health Group. Calm, a mental wellness brand with an app for sleep, meditation and...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised FTX on the deal. FTX, owner and operator of FTX.COM, announced its $400 Million Series C financing. The round saw participation from Temasek,...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised The New York Times Company on the deal. The New York Times Company announced its acquisition of Wordle, Josh Wardle’s popular daily word game....
You must be a Standard 1 Year member to access this content.
Fenwick & West advised CaptivateIQ on the deal. CaptivateIQ, a sales commissions platform, announced its $100 million Series C financing. The round was led by ICONIQ Growth,...
You must be a Standard 1 Year member to access this content.
Fenwick & West and Willkie Farr & Gallagher advised Wealthfront on the deal. Wealthfront, an automated wealth management provider serving the next generation of investors, announced...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...
You must be a Standard 1 Year member to access this content.
Fenwick represented Bolt on the deal. Bolt, an online checkout experience platform, announced its Series E financing. The round was led by BlackRock with participation from new...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised 6Sense on the deal. 6Sense, a leading platform for B2B organizations generating predictable revenue, announced its $200 million Series E financing. The round...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Lyra Health on the deal. Lyra Health, a leading provider of innovative Workforce Mental Health solutions for employers, announced its $235 million financing....
You must be a Standard 1 Year member to access this content.
Fenwick & West and Wilson Sonsini Goodrich & Rosati advised Metagenomi on the deal while Gunderson Dettmer represented PFM Health Sciences. Metagenomi, a genetic medicines company...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Royalty Pharma on the deal. Royalty Pharma (Nasdaq: RPRX), a buyer of biopharmaceutical royalties and funder of innovation across the biopharmaceutical industry,...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised TigerConnect on the deal. TigerConnect, maker of a powerful healthcare software collaboration suite, announced its strategic growth investment from Vista Equity Partners, a...
You must be a Standard 1 Year member to access this content.
